Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Retatrutide's approximately 6-day half-life directly supports a once-weekly subcutaneous injection regimen, maintaining relatively stable plasma drug levels between doses and mirroring the dosing schedules of other long-acting incretin-based therapies such as semaglutide and tirzepatide
& Sparks, L
Younger patients: These people may need tests for blood clotting issues, optic disc drusen or sleep apnea to rule out other conditions
Retrieved 14 May 2022, from A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients with Xeroderma Pigmentosum (XP)
US$ 25.08
US$ 22.04
US$ 29.67
US$ 21.93
US$ 22.63
US$ 27.38
US$ 24.36
US$ 25.80
US$ 29.91
US$ 25.78
